Shockwave Medical Inc Quick Ratio (SWAV) starting from the first quarter 2024 to first quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Shockwave Medical Inc   (NASDAQ: SWAV)

Shockwave Medical Inc 's Quick Ratio

SWAV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Shockwave Medical Inc 's Cash & cash equivalent grew by 3.9 % in the Q1 2024 sequentially, while Current Liabilities decreased, this led to improvement in Shockwave Medical Inc 's Quick Ratio to 11.15, above Shockwave Medical Inc average Quick Ratio.

Within Medical Equipment & Supplies industry Shockwave Medical Inc booked the highest Quick Ratio than Shockwave Medical Inc in the first quarter 2024. While Quick Ratio total ranking has improved so far during the Q1 2024 to 51, from total ranking in the fourth quarter 2023 at 372.

Explain Quick Ratio?
How much Cash & cash equivalents SWAV´s has?
What are SWAV´s Current Liabilities?




SWAV Quick Ratio (Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
Y / Y Current Liabilities Change -34.98 % 79.43 % 44.23 % 21.17 % 178.26 %
Y / Y Cash & cash equivalent Change 146.9 % 225.31 % 265.96 % 14.98 % 107.26 %
Quick Ratio MRQ 11.15 8.71 11.73 3.22 2.94
SWAV's Total Ranking # 51 # 372 # 70 # 946 # 818
Seq. Current Liabilities Change -18.8 % 45.41 % -2.51 % -43.51 % 124.06 %
Seq. Cash & cash equivalent Change 3.9 % 7.98 % 254.75 % -37.97 % 36.9 %



Quick Ratio first quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 0
Healthcare Sector # 13
Overall Market # 51


Quick Ratio Statistics
High Average Low
13.04 6.94 2.94
(Jun 30 2020)   (Mar 31 2023)




Financial Statements
Shockwave Medical Inc 's Current Liabilities $ 92 Millions Visit SWAV's Balance sheet
Shockwave Medical Inc 's Cash & cash equivalent $ 1,029 Millions Visit SWAV's Balance sheet
Source of SWAV's Sales Visit SWAV's Sales by Geography


Cumulative Shockwave Medical Inc 's Quick Ratio

SWAV's Quick Ratio for the trailling 12 Months

SWAV Quick Ratio

(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 11.87 % 76.35 % 63.07 % 62.49 % 82.09 %
Y / Y Cash & cash equivalent TTM Growth 166.99 % 163.29 % 116.17 % 51.93 % 57.53 %
Quick Ratio TTM 8.77 6.24 5.22 3.62 3.67
Total Ranking TTM # 3515 # 44 # 3318 # 3417 # 3356
Seq. Current Liabilities TTM Growth -11.99 % 13.84 % 7.06 % 4.3 % 38.74 %
Seq. Cash & cash equivalent TTM Growth 23.7 % 36.16 % 54.17 % 2.81 % 21.99 %


On the trailing twelve months basis SWAV Cash & cash equivalent more than doubled by 146.9 % in Q1 2024 year on year, while Current Liabilities faded to $92 millions, this led to increase in in Shockwave Medical Inc 's Quick Ratio to 8.77, above SWAV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Shockwave Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2023 from 44 to 3515.

Explain Quick Ratio?
How much Cash & cash equivalents SWAV´s has?
What are SWAV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 204
Healthcare Sector # 983
Within the Market # 3515


trailing twelve months Quick Ratio Statistics
High Average Low
9.95 5.98 0.89
(Sep 30 2020)   (Mar 31 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2024, within Medical Equipment & Supplies Industry Quick RatioMar 31 2024 MRQ Cash & cash equivalentMar 31 2024 MRQ Current Liabilities
Envveno Medical Corporation  28.88 $ 42.942  Millions$ 1.487  Millions
Bone Biologics Corporation  22.08 $ 3.228  Millions$ 0.146  Millions
Talkspace Inc   20.72 $ 120.278  Millions$ 5.805  Millions
Utah Medical Products Inc  17.14 $ 93.808  Millions$ 5.474  Millions
Soleno Therapeutics Inc  13.91 $ 149.627  Millions$ 10.759  Millions
Semler Scientific inc   12.79 $ 62.754  Millions$ 4.907  Millions
Perspective Therapeutics Inc   12.46 $ 180.648  Millions$ 14.503  Millions
Pulse Biosciences Inc   12.40 $ 34.885  Millions$ 2.813  Millions
Retractable Technologies Inc  12.29 $ 46.642  Millions$ 3.796  Millions
Vicarious Surgical Inc  12.10 $ 73.230  Millions$ 6.050  Millions
Heartbeam Inc   11.52 $ 12.638  Millions$ 1.097  Millions
Inmode Ltd   11.23 $ 596.472  Millions$ 53.096  Millions
Shockwave Medical Inc   11.15 $ 1,029.233  Millions$ 92.334  Millions
Autonomix Medical Inc   11.08 $ 8.608  Millions$ 0.777  Millions
Sight Sciences Inc   10.89 $ 127.284  Millions$ 11.693  Millions
Novocure Limited  10.32 $ 870.147  Millions$ 84.316  Millions
Femasys Inc   10.08 $ 17.836  Millions$ 1.769  Millions
Inspire Medical Systems inc   9.77 $ 441.361  Millions$ 45.190  Millions
Nevro Corp   9.61 $ 281.483  Millions$ 29.292  Millions
Cvrx inc   9.54 $ 80.115  Millions$ 8.398  Millions
Neurometrix Inc   9.53 $ 17.599  Millions$ 1.847  Millions
Co diagnostics Inc   9.48 $ 49.964  Millions$ 5.270  Millions
Fractyl Health Inc   9.15 $ 121.441  Millions$ 13.272  Millions
Orasure Technologies Inc  9.06 $ 263.772  Millions$ 29.105  Millions
Alpha Pro Tech Ltd   8.96 $ 18.510  Millions$ 2.065  Millions
Modular Medical Inc  8.53 $ 9.232  Millions$ 1.082  Millions
Silk Road Medical Inc   8.18 $ 174.462  Millions$ 21.337  Millions
Orchestra Biomed Holdings Inc   7.54 $ 75.038  Millions$ 9.951  Millions
Irhythm Holdings Inc   7.25 $ 569.092  Millions$ 78.484  Millions
Hyperfine Inc   7.21 $ 63.204  Millions$ 8.767  Millions

Date modified: 2026-09-08T15:11:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.